Related Experiment Video
Updated: Jan 5, 2026
04:44
Author Spotlight: Regenerative Roles of Muscle Proteins at Neuromuscular Junction Post-Nerve Injury
Published on: November 1, 2024
854
Corticosteroids for Bell's palsy (idiopathic facial paralysis)
Rodrigo A Salinas1, Gonzalo Alvarez, Fergus Daly
1Department of Neurological Sciences, Universidad de Chile, Av. Salvador 364, Santiago, Chile, 7500922.
The Cochrane Database of Systematic Reviews
|March 19, 2010
Summary
Corticosteroid therapy significantly improves facial motor function recovery in Bell's palsy patients. This treatment reduces incomplete recovery and motor synkinesis, offering a beneficial intervention for this condition.
Area of Science:
- Neurology
- Clinical Trials
- Pharmacology
Background:
- Bell's palsy is associated with inflammation and edema of the facial nerve.
- Corticosteroids possess potent anti-inflammatory properties that may mitigate nerve damage.
Purpose of the Study:
- To evaluate the efficacy of corticosteroid therapy for Bell's palsy.
- To assess the impact of corticosteroids on facial nerve recovery and associated symptoms.
Main Methods:
- Systematic review and meta-analysis of randomized controlled trials (RCTs).
- Searched multiple databases (Cochrane, MEDLINE, EMBASE, LILACS) and contacted experts for relevant trials.
- Included RCTs comparing corticosteroid therapy (various dosages/routes) against control groups.
Main Results:
- Eight trials with 1569 participants were analyzed.
- Corticosteroid treatment significantly reduced incomplete facial motor function recovery at six months (23% vs. 33%).
- A significant reduction in motor synkinesis was observed in the corticosteroid group.
Conclusions:
- Randomized controlled trials provide significant evidence supporting the use of corticosteroids for Bell's palsy.
- Corticosteroid therapy demonstrates clear benefits in improving patient outcomes for Bell's palsy.
Related Concept Videos
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
388
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
388
01:20Myasthenia Gravis: Overview and Treatment
2.7K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.7K
01:31Skeletal Muscle Relaxants: Therapeutic Uses
846
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
846
01:28Classification of Skeletal Muscle Relaxants
3.0K
Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
3.0K
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
1.5K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.5K
01:24Parkinson's Disease: Treatment
916
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
916